COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,610 Articles (22,913 medRxiv, 8,697 bioRxiv)

Most recent first Previous |  Page 1154: Articles 11531-11540  | Next

SARS-CoV-2 papain-like protease PLpro in complex with natural compounds reveal allosteric sites for antiviral drug design
Srinivasan, V., Brognaro, H., Prabhu, P. R., de Souza, E. E., Guenther, S., Reinke, P. Y. A., J. Lane, T., Ginn, H., Han, H., Ewert, W., Sprenger, J., Koua, F. H. M., Falke, S., Werner, N., Andaleeb, H., Ullah, N., Alves Franca, B., Wang, M., Luana C Barra, A., Perbandt, M., Schwinzer, M., Schmidt, C., Brings, L., Lorenzen, K., Schubert, R., Rahal Guaragna Machado, R., Donizette Candido, E., Bruna Leal Oliveira, D., Luiz Durigon, E., Yefanov, O., Lieske, J., Gelisio, L., Domaracky, M., Middendorf, P., Groessler, M., Trost, F., Galchenkova, M., Saouane, S., Hakanpaeae, J., Wolf, M., Turk, D., Pearson, A. R., Chapman, H. N., Hinrichs, W., Wrenger, C., Meents, A., Betzel, C.
10.1101/2021.11.17.468943 — Posted: 2021-11-22
ACE2 expression and localization are regulated by CFTR: implications beyond cystic fibrosis
Bezzerri, V., Gentili, V., Api, M., Finotti, A., Papi, C., Tamanini, A., Olioso, D., Duca, M., Tedesco, E., Leo, S., Borgatti, M., Volpi, S., Pinton, P., Cabrini, G., Gambari, R., Blasi, F., Lippi, G., Rimessi, A., Rizzo, R., cipolli, m.
10.1101/2021.11.19.469220 — Posted: 2021-11-22
Clinical Outcome of Neurological patients with COVID-19: the impact of Healthcare organization improvement between waves.
Cristillo, V., Pilotto, A., Benussi, A., Libri, I., Giunta, M., Morotti, A., Gipponi, S., Locatelli, M., Cotti Piccinelli, S., Mazzoleni, V., Schiano di Cola, F., Masciocchi, S., Pezzini, D., Scalvini, A., Premi, E., Cottini, E., Gamba, M., Magoni, M., Fontanella, M. M., Padovani, A.
10.1101/2021.11.19.21266606 — Posted: 2021-11-22
The Effect of COVID-19 on the Postdoctoral Experience: a comparison of pre-pandemic and pandemic surveys.
Morin, A., Helling, B. A., Krishnan, S., Risner, L. E., Walker, N. D., Schwartz, N. B.
10.1101/2021.11.19.468693 — Posted: 2021-11-21 Discussion: Offsite
ROLE OF BODY MASS AND PHYSICAL ACTIVITY IN AUTONOMIC FUNCTION MODULATION ON POST-COVID-19 CONDITION: AN OBSERVATIONAL SUBANALYSIS OF FIT-COVID STUDY
Freire, A. P. F., Santos de Lira, F., von Ah Morano, A. E., Pereira, T., Coelho Silva, M.-J., Caseiro, A., Destro Christofaro, D. G., Marchioto, O., Pires Dorneles, G., Aurino Pinho, R., Spolador de Alencar Silva, B.
10.1101/2021.11.17.21266473 — Posted: 2021-11-21
Antibody titers before and after booster doses of SARS-CoV-2 mRNA vaccines in healthy adults
Demonbreun, A. R., Sancillo, A., Vaught, L. A., Reiser, N. L., Pesce, L., McNally, E. M., McDade, T. W.
10.1101/2021.11.19.21266555 — Posted: 2021-11-21 Discussion: Onsite
Patient experience with healthcare: Feedback for a Post COVID-19 clinic at a tertiary care center in rural area
Garg, A., Subramain, M., Barlow, P. B., Garvin, L., Hoth, K. F., Dukes, K., Hoffman, R. M., Comellas, A. P.
10.1101/2021.11.20.21266640 — Posted: 2021-11-21
Race-Specific, U.S. State-Specific COVID-19 Vaccination Rates Adjusted for Age
Wrigley-Field, E., Berry, K. M., Persad, G.
10.1101/2021.11.19.21266612 — Posted: 2021-11-21
Very high relative seroprevalence of anti-SARS-CoV-2 antibodies among communities in Bangui, Central African Republic
Manirakiza, A., Malaka, C., Yambiyo, B. M., Diemer, S. C. H., Longo, J. d. D., Namsenei, J., Coti-Reckoundji, C. S. G., Bouhouda, M., Darnycka, B. M. R., Roungou, J. B., Komas, N. P., Gresenguet, G., Vernet, G., Vernet, M.-A., Nakoune, E.
10.1101/2021.11.18.21266496 — Posted: 2021-11-21
SeroTracker-ROB: reproducible decision rules for risk of bias assessment of seroprevalence studies
Bobrovitz, N., Noel, K. C., Li, Z., Cao, C., Deveaux, G., Selemon, A., Yanes Lane, M., Yan, T., Arora, R. K.
10.1101/2021.11.17.21266471 — Posted: 2021-11-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).